Who is sponsoring NCT05476666?

NCT05476666 is sponsored by Pakistan Navy Station Shifa Hospital.

What drugs are being tested in NCT05476666?

Interventions in NCT05476666: Peripherial and central venous access.

What condition does NCT05476666 study?

NCT05476666 studies Peripherial Venous Pressure, Central Venous Pressure, Fluid/Volume Status Monitoring of Patient.

Is NCT05476666 still recruiting?

NCT05476666 is currently completed. Last updated 3 August 2022.

Last reviewed 2022-08-03 · How we verify

NCT05476666

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peripheral Venous Pressure as an Indicator of Central Venous Pressure in Post Operative Surgical Patients: A Randomised Controlled Trial

Completed NA Last updated 3 August 2022

What this trial tests

NA trial testing Peripherial and central venous access in Peripherial Venous Pressure in 40 participants. Completed in 15 June 2022.

Timeline

1 March 2022

Primary endpoint
31 May 2022

15 June 2022

Quick facts

Lead sponsor	Pakistan Navy Station Shifa Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	1 March 2022
Primary completion	31 May 2022
Estimated completion	15 June 2022
Sites	1 location across Pakistan

Drugs / interventions tested

Peripherial and central venous access

Conditions studied

Peripherial Venous Pressure — all drugs for Peripherial Venous Pressure →
Central Venous Pressure — all drugs for Central Venous Pressure →
Fluid/Volume Status Monitoring of Patient — all drugs for Fluid/Volume Status Monitoring of Patient →

Sponsor

Pakistan Navy Station Shifa Hospital

Who can join

Adults 18 to 75, any sex, with Peripherial Venous Pressure or Central Venous Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed at comparing peripherial venous pressure as an indicator of central venous pressure in post operative surgical patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Pakistan Navy Station Shifa Hospital trials

Trials by the same sponsor.

NCT07122596 — EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS · Phase 4 · completed
NCT06812741 — Duration of Postop Analgesia After Inguinal Hernia Surgery Treated with TAP Block Vs II/IH Nerve Block · Phase 3 · completed
NCT06065956 — Comparison of Hemodynamic Changes With Morphine Versus Esmolol During Induction of Anaesthesia · Phase 1, PHASE2 · completed
NCT05489809 — Endotracheal Extubation With Suctioning Versus Positive Pressure in Children After General Anaesthesia. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05476666 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pakistan Navy Station Shifa Hospital
Last refreshed: 3 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05476666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing